Current filters:

Astellas PharmaRoche

Additional indications in Japan for Roche's Avastin and Astellas' Prograf


Swiss drug major Roche (ROG: SIX) says that the Japanese Ministry of Health, Labor and Welfare (MHLW)…

Asia-PacificAstellas PharmaAvastinBiotechnologyImmunologicalsOncologyPharmaceuticalPrografRegulationRoche

Combination of Advagraf and CellCept led to less organ rejection; study


For the thousands of patients who receive kidney transplants in the USA each year, preventing organ rejection…

AdvagrafAstellas PharmaCellCeptImmunologicalsPharmaceuticalResearchRoche

Astellas goes hostile, offering a 40% premium to buy OSI Pharma for $3.5 billion


Despite previous rejections of its advances, Japanese drug major Astellas Pharma this morning said it…

Astellas PharmaerlotinibGenentechGilead SciencesGiliad SciencesMergers & AcquisitionsPharmaceuticalRocheTarceva

Back to top